{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:35:00Z","timestamp":1761514500258,"version":"3.41.2"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02984","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T14:14:10Z","timestamp":1576678450000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection"],"prefix":"10.3389","volume":"10","author":[{"given":"Baila","family":"Samreen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Tischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein-Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin Microbiol Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/sj.jid.5700083","article-title":"Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma","volume":"126","author":"Pellet","year":"2006","journal-title":"J Invest Dermatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.canlet.2011.03.003","article-title":"Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients","volume":"305","author":"Cesarman","year":"2011","journal-title":"Cancer Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S0140-6736(96)90989-7","article-title":"HHV8 cell-associated viraemia and clinical presentation of Mediterranean Kaposi's sarcoma","volume":"347","author":"Brambilla","year":"1996","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science."},{"key":"B7","first-page":"2511","article-title":"Epstein-Barr virus and its replication","volume-title":"Fields Virology.","author":"Kieff","year":"2001"},{"key":"B8","first-page":"61","article-title":"Therapy of lymphoma directed at idiotypes","volume":"10","author":"Levy","year":"1990","journal-title":"J Natl Cancer Inst Monogr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.4049\/jimmunol.165.2.1074","article-title":"Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages","volume":"165","author":"Flano","year":"2000","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/306480a0","article-title":"Replication of Epstein-Barr virus in human epithelial cells infected in vitro","volume":"306","author":"Sixbey","year":"1983","journal-title":"Nature."},{"key":"B12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.175.4018.202","article-title":"Morphological transformation in vitro of human embryo fibroblasts by Epstein-Barr virus: preliminary observations","volume":"175","author":"Probert","year":"1972","journal-title":"Science."},{"key":"B13","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1128\/JVI.71.8.5894-5904.1997","article-title":"Complete sequence and genomic analysis of murine gammaherpesvirus 68","volume":"71","author":"Virgin","year":"1997","journal-title":"J. Virol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/978-0-387-68945-6_28","article-title":"Murine gammaherpesvirus 68 infection of mice: a small animal model for characterizing basic aspects of gammaherpesvirus pathogenesis","volume-title":"DNA Tumor Viruses","author":"Forrest","year":"2009"},{"key":"B15","doi-asserted-by":"crossref","first-page":"9849","DOI":"10.1128\/JVI.73.12.9849-9857.1999","article-title":"T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice","volume":"73","author":"Liu","year":"1999","journal-title":"J Virol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7696","DOI":"10.1128\/JVI.77.13.7696-7701.2003","article-title":"Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection","volume":"77","author":"Tibbetts","year":"2003","journal-title":"J Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6723","DOI":"10.1016\/j.vaccine.2009.08.104","article-title":"Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load","volume":"27","author":"Hoegh-Petersen","year":"2009","journal-title":"Vaccine."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1128\/JVI.01543-09","article-title":"Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency","volume":"84","author":"Jia","year":"2010","journal-title":"J Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"10829","DOI":"10.1128\/JVI.78.19.10829-10832.2004","article-title":"T-cell responses to the M3 immune evasion protein of murid gammaherpesvirus 68 are partially protective and induced with lytic antigen kinetics","volume":"78","author":"Obar","year":"2004","journal-title":"J Virol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8283","DOI":"10.1128\/JVI.75.17.8283-8288.2001","article-title":"Latent antigen vaccination in a model gammaherpesvirus infection","volume":"75","author":"Usherwood","year":"2001","journal-title":"J Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1099\/vir.0.023085-0","article-title":"Vaccination with murid herpesvirus-4 glycoprotein B reduces viral lytic replication but does not induce detectable virion neutralization","volume":"91","author":"May","year":"2010","journal-title":"J Gen Virol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0264-410X(98)00190-X","article-title":"Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination","volume":"17","author":"Stewart","year":"1999","journal-title":"Vaccine."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1128\/JVI.02229-09","article-title":"Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection","volume":"84","author":"Freeman","year":"2010","journal-title":"J Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1099\/0022-1317-73-9-2347","article-title":"Virological and pathological features of mice infected with murine gamma-herpesvirus 68","volume":"73","author":"Sunil-Chandra","year":"1992","journal-title":"J Gen Virol."},{"key":"B25","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L","article-title":"Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection","volume":"29","author":"Stevenson","year":"1999","journal-title":"Eur J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1128\/JVI.77.4.2410-2417.2003","article-title":"Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency","volume":"77","author":"Coleman","year":"2003","journal-title":"J Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S1357-4310(00)01813-X","article-title":"Murine gamma-herpesvirus-68: a mouse model for infectious mononucleosis?","volume":"6","author":"Blackman","year":"2000","journal-title":"Mol Med Tdy."},{"key":"B28","doi-asserted-by":"publisher","first-page":"9281","DOI":"10.1073\/pnas.96.16.9281","article-title":"A gamma-herpesvirus sneaks through a CD8 (+) T cell response primed to a lytic-phase epitope","volume":"96","author":"Stevenson","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"B29","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4049\/jimmunol.163.2.868","article-title":"Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection","volume":"163","author":"Liu","year":"1999","journal-title":"J Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"8303","DOI":"10.1128\/JVI.00237-06","article-title":"Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection","volume":"80","author":"Obar","year":"2006","journal-title":"J Virol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.4049\/jimmunol.1302060","article-title":"CD4 T cells specific for a latency-associated \u03b3-herpesvirus epitope are polyfunctional and cytotoxic","volume":"193","author":"Freeman","year":"2014","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.3390\/v6072735","article-title":"Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases","volume":"6","author":"Altenburg","year":"2014","journal-title":"Viruses."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1016\/j.vaccine.2013.03.020","article-title":"Clinical development of Modified Vaccinia virus Ankara vaccines","volume":"31","author":"Gilbert","year":"2013","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1586\/14760584.2013.845531","article-title":"Clinical applications of attenuated MVA poxvirus strain","volume":"12","author":"Gomez","year":"2013","journal-title":"Expert Rev Vaccines."},{"key":"B35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jviromet.2010.04.012","article-title":"Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome","volume":"168","author":"Cottingham","year":"2010","journal-title":"J Virol Methods."},{"key":"B36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/978-1-60761-652-8_30","article-title":"En passant mutagenesis: a two step markerless red recombination system","volume":"634","author":"Tischer","year":"2010","journal-title":"Methods Mol Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1128\/JVI.03244-14","article-title":"Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways","volume":"89","author":"Thiele","year":"2015","journal-title":"J Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1128\/JVI.74.15.6964-6974.2000","article-title":"Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome","volume":"74","author":"Adler","year":"2000","journal-title":"J Virol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1385\/1-59259-789-0:077","article-title":"Construction and isolation of recombinant MVA","volume":"269","author":"Staib","year":"2004","journal-title":"Methods Mol Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"472537","DOI":"10.1155\/2012\/472537","article-title":"Viral bacterial artificial chromosomes: generation, mutagenesis, and removal of mini-F sequences","volume":"2012","author":"Tischer","year":"2012","journal-title":"J Biomed Biotechnol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e1638","DOI":"10.1371\/journal.pone.0001638","article-title":"Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA)","volume":"3","author":"Cottingham","year":"2008","journal-title":"PLoS ONE."},{"key":"B42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J Gen Virol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1084\/jem.20070489","article-title":"Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination","volume":"204","author":"Kastenmuller","year":"2007","journal-title":"J Exp Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.1128\/JVI.00629-09","article-title":"The M10 locus of murine gammaherpesvirus 68 contributes to both the lytic and the latent phases of infection","volume":"83","author":"Flach","year":"2009","journal-title":"J Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"13200","DOI":"10.1128\/JVI.01148-07","article-title":"A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9","volume":"81","author":"Tischer","year":"2007","journal-title":"J Virol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2144\/000112096","article-title":"Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli","volume":"40","author":"Tischer","year":"2006","journal-title":"Biotechniques."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1016\/j.vaccine.2013.03.021","article-title":"Recombinant MVA vaccines: dispelling the myths","volume":"31","author":"Cottingham","year":"2013","journal-title":"Vaccine."},{"key":"B48","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.1128\/JVI.00604-10","article-title":"Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses","volume":"84","author":"Baur","year":"2010","journal-title":"J Virol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.4049\/jimmunol.170.7.3828","article-title":"Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice","volume":"170","author":"Flano","year":"2003","journal-title":"J Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1099\/0022-1317-77-11-2819","article-title":"Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice","volume":"77","author":"Usherwood","year":"1996","journal-title":"J Gen Virol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"11925","DOI":"10.1128\/JVI.00903-07","article-title":"Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines","volume":"81","author":"Gasteiger","year":"2007","journal-title":"J Virol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.cell.2015.08.004","article-title":"Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions","volume":"162","author":"Eickhoff","year":"2015","journal-title":"Cell."},{"key":"B53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.immuni.2017.01.003","article-title":"CD8(+) T cells orchestrate pDC-XCR1(+) dendritic cell spatial and functional cooperativity to optimize priming","volume":"46","author":"Brewitz","year":"2017","journal-title":"Immunity."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e1003129","DOI":"10.1371\/journal.ppat.1003129","article-title":"Kinetics of antigen expression and epitope presentation during virus infection","volume":"9","author":"Croft","year":"2013","journal-title":"PLoS Pathog."},{"key":"B55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines","volume":"201","author":"Tscharke","year":"2005","journal-title":"J Exp Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2217\/fmb.09.110","article-title":"Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens","volume":"5","author":"Moutaftsi","year":"2010","journal-title":"Future Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/vaccines2030581","article-title":"Gene expression driven by a strong viral promoter in MVA increases vaccination efficiency by enhancing antibody responses and unmasking CD8(+) T cell epitopes","volume":"2","author":"Becker","year":"2014","journal-title":"Vaccines."},{"key":"B58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.smim.2009.02.006","article-title":"CD4 memory T cells: what are they and what can they do?","volume":"21","author":"MacLeod","year":"2009","journal-title":"Semin Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1056\/NEJMoa1411627","article-title":"A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA","volume":"374","author":"Ewer","year":"2016","journal-title":"N Engl J Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e0118486","DOI":"10.1371\/journal.pone.0118486","article-title":"Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults","volume":"10","author":"Joachim","year":"2015","journal-title":"PLoS ONE."},{"key":"B61","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1128\/IAI.00740-09","article-title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses","volume":"78","author":"Reyes-Sandoval","year":"2010","journal-title":"Infect Immun."},{"key":"B62","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/v9100308","article-title":"Gammaherpesviral tegument proteins, PML-nuclear bodies and the ubiquitin-proteasome system","volume":"9","author":"Full","year":"2017","journal-title":"Viruses."},{"key":"B63","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1128\/JVI.67.9.5247-5252.1993","article-title":"Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells","volume":"67","author":"Ehtisham","year":"1993","journal-title":"J Virol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1099\/0022-1317-77-4-627","article-title":"Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells","volume":"77","author":"Usherwood","year":"1996","journal-title":"J Gen Virol."},{"key":"B65","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1128\/JVI.70.10.6775-6780.1996","article-title":"Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68","volume":"70","author":"Weck","year":"1996","journal-title":"J Virol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1084\/jem.184.3.863","article-title":"Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells","volume":"184","author":"Cardin","year":"1996","journal-title":"J Exp Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1073\/pnas.040575197","article-title":"Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice","volume":"97","author":"Belz","year":"2000","journal-title":"Proc Natl Acad Sci USA."},{"key":"B68","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1128\/JVI.71.6.4278-4283.1997","article-title":"Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells","volume":"71","author":"Dutia","year":"1997","journal-title":"J Virol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/nm1297-1346","article-title":"Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease","volume":"3","author":"Weck","year":"1997","journal-title":"Nat Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1098\/rstb.2000.0779","article-title":"Natural history of murine gamma-herpesvirus infection","volume":"356","author":"Nash","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-immunol-072710-081639","article-title":"Pathogenesis and host control of gammaherpesviruses: lessons from the mouse","volume":"29","author":"Barton","year":"2011","journal-title":"Annu Rev Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.cell.2015.10.054","article-title":"SnapShot: T cell exhaustion","volume":"163","author":"Pauken","year":"2015","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Front Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1099\/vir.0.19592-0","article-title":"Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant","volume":"85","author":"Boname","year":"2004","journal-title":"J Gen Virol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1099\/vir.0.19760-0","article-title":"Vaccine potential of a murine gammaherpesvirus-68 mutant deficient for ORF73","volume":"85","author":"Fowler","year":"2004","journal-title":"J Gen Virol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"9215","DOI":"10.1128\/JVI.78.17.9215-9223.2004","article-title":"Generation of a latency-deficient gammaherpesvirus that is protective against secondary infection","volume":"78","author":"Rickabaugh","year":"2004","journal-title":"J Virol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1128\/JVI.77.4.2522-2529.2003","article-title":"Effective vaccination against long-term gammaherpesvirus latency","volume":"77","author":"Tibbetts","year":"2003","journal-title":"J Virol."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12299","article-title":"Vaccine protection against Murid Herpesvirus-4 is maintained when the priming virus lacks known latency genes","author":"Lawler","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1172\/JCI125364","article-title":"Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas","volume":"129","author":"Ruhl","year":"2019","journal-title":"J Clin Invest."},{"key":"B81","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.vaccine.2015.11.062","article-title":"Prime-boost vaccine strategy against viral infections: mechanisms and benefits","volume":"34","author":"Kardani","year":"2016","journal-title":"Vaccine."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.vaccine.2019.04.034","article-title":"CD8+ T cells induced by adenovirus-vectored vaccine are capable of preventing establishment of latent murine \u03b3-herpesvirus 68 infection","volume":"37","author":"Boilesen","year":"2019","journal-title":"Vaccine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02984\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T05:09:31Z","timestamp":1695532171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02984\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,18]]},"references-count":82,"alternative-id":["10.3389\/fimmu.2019.02984"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02984","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2019,12,18]]},"article-number":"2984"}}